Literature DB >> 34422376

Association between individual surgeon volume and outcome in mitral valve surgery: a systematic review.

Berdel Akmaz1,2, Sander M J van Kuijk3, Peyman Sardari Nia2.   

Abstract

BACKGROUND: Surgeon volume has been identified as a possible factor that influences outcomes in mitral valve (MV) surgery. The aim of this study was to systematically review all published studies on the association between individual surgeon volume and outcome in MV surgery.
METHODS: PubMed was searched last on 19 November 2020. The reporting of this systematic review was done in accordance with PRISMA guidelines. Manuscripts were eligible when these studied individual surgeon volumes and its association with repair rate, mortality or reoperation. The methodological quality of the studies was assessed with the Newcastle-Ottawa Scale (NOS). Absolute numbers and percentages of the outcome measures, odds ratios (ORs), P values and threshold values regarding surgeon volume were collected.
RESULTS: A total of 7 retrospective cohort studies were included in the qualitative analysis with total of 158488 patients. Definitions of surgeon volumes were found to be heterogenic and therefore pooling of data was not possible. Surgeon volume was significantly associated with repair rate (OR =1.25-5.5) and mortality (OR =0.46-0.84 and OR =1.50-2.27 depending on the reference group). Regarding reoperation, results were not consistent and did not always show a significant lower reoperation rate when surgeon volume increased. A mean threshold of minimally 30 MV surgeries per year was found. DISCUSSION: Higher surgeon volume is significantly associated with improved outcomes of repair rate and mortality. MV should preferentially be performed by high-volume surgeons and centralization of MV surgery might be necessary. 2021 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Mitral valve surgery (MV surgery); mortality; reoperation; repair rate; surgeon volume

Year:  2021        PMID: 34422376      PMCID: PMC8339780          DOI: 10.21037/jtd-21-578

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


Introduction

The burden of valvular heart diseases in the general population is considerable and its prevalence is estimated at 2.5% (1). Mitral valve (MV) repair is considered the gold standard for treating degenerative MV disease and is superior to MV replacement (2-6). MV repair is performed using full median sternotomy or minithoracotomy (with endoscopic or robotic assistance). The durability of the repair and the repair rate are dependent on the surgeon’s experience and the nature of the MV pathology (2). Literature shows an association between hospital volume and outcomes in MV surgery (7,8). Higher-volume hospitals were found to have lower operative mortality rates than smaller hospitals for MV surgery. High individual surgeon’s volume might also increase the likelihood of durable MV repair, the repair rate and improved outcomes (7,9). Surgeon experience accounts for a large amount of the effect hospital volume has on outcomes and is associated with mortality in cardiovascular procedures (10). Surgeon volumes may therefore be more important than hospital volumes (8,9,11). It was proposed that surgeons need a volume of 25 MV repairs per year to provide consistency in their outcome. However, these numbers are based on thresholds of urological malignancy in the UK which might not be representative for valve surgery (8,12). Despite the possible association between surgeon volume and outcomes, no consensus on the association between surgeon volume and outcomes for MV surgery exists (8,12). In the literature, several systematic reviews regarding surgeon volume for other surgical specialties have been performed (13,14). However, reviews considering the relationship between surgeon volume and outcomes in MV surgery are still lacking (11,15). Therefore, the aim of this study is to systematically review all published studies on the association between individual surgeon volume and outcome in adult MV surgery patients. We present the following article in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) reporting checklist (16) (available at https://dx.doi.org/10.21037/jtd-21-578).

Methods

A study protocol was designed and used based on the guidelines described in the Cochrane Reviewers’ Handbook (17). Inclusion and exclusion criteria, outcome measures and methods of the analysis were described in the protocol.

Participants, intervention and outcomes

Manuscripts were included when these studied individual surgeon volume and its association with one of the predefined outcome measures. Surgeon volumes were defined as low-volume or high-volume using the volume categories of each study and defining the lowest volume category in the studies as reference. Outcome measures were repair rate, mortality and reoperation per surgeon volume. ‘Repair rate’ was defined as a percentage for the degree of repair of the MV, per surgeon volume group. ‘Mortality’ was defined per surgeon volume group as operative mortality, 30-day mortality or 1-year mortality, which differed per study. The outcome ‘Reoperation’ was defined in absolute numbers and percentages per surgeon volume group.

Search strategy

PubMed was searched for studies from 1978 up to November 2020 regarding the influence of individual surgeon volume on repair rate, mortality and reoperation in MV surgery patients. Additional studies were sought via Embase. The Cochrane review database was used to search for existing systematic reviews on this topic. Furthermore, reference lists of the articles were checked on relevant literature. The search included the following (MeSH) search terms: ‘Mitral valve insufficiency’, ‘Mitral valve prolapse’, ‘Mitral valve stenosis’, ‘Mitral valve annuloplasty’, ‘Mitral valve surgery’, ‘Mitral valve repair’, ‘High-volume surgeons’, ‘Low-volume surgeons’, ‘Surgeon volume’, ‘Clinician volume’, ‘Physician volume’, ‘Cardiac Surgical Procedures/mortality’, ‘Repair rate’, ‘Reoperation’ and ‘Recovery’. To reflect total annual mitral experience, the search included both MV repairs and replacements. The last search was run on 19 November 2020. The reproducible search string can be found in the Appendix 1.

Study selection

Articles were first screened for eligibility based on their titles and abstracts. Subsequently, full texts of the potentially eligible studies were read according to the predefined eligibility criteria. Articles reporting combined data were only included when data for MV surgery was presented separately. Experimental or cohort studies were included only. Studies were excluded when they were not available in English, not in full-text or when these considered hospital volumes instead of surgeon volumes. Furthermore, studies describing learning curves of (trainee) surgeons were excluded because these do not describe individual annual case volumes.

Data extraction

Data extraction tables were drafted by two authors independently, and information on the following study characteristics were collected for each article: study period, setting, study design, MV repair or replacement, participants in total (male/female), age and outcome measure (repair rate, mortality, reoperation). Measures of association that were included are odds ratios (ORs), relative risks (RRs) and hazard ratios (HRs), including 95% confidence intervals (CIs) and P values. In case these were not given, the appropriate measure of association was calculated. Furthermore, threshold values were included in case these were described. Assessment of study quality was done using the Newcastle-Ottawa Scale (NOS) quality assessment scale. Studies scoring 7 or higher were defined as high methodological quality. Studies scoring 5 or lower were considered as low methodological quality.

Statistical analysis

Definitions of surgeon volumes were found to be heterogeneous and therefore pooling of data was not possible. Data was described qualitatively reporting absolute numbers and ORs or HRs. If available, adjusted ORs (AORs) or HRs were reported. In case no numerical results were reported, numbers were estimated from published figures or scatter plots. Missing ORs were calculated for four studies: higher volume was defined as the ‘exposed group’, compared to a ‘control group’ with low volume.

Results

Seventy-two articles were found on PubMed and used for this review. One additional study was found by related-article search. No duplicates were included. After title and abstract screening, 13 full texts were assessed for eligibility (). Five did not meet the eligibility criteria and were excluded because the measured outcomes were different than our predefined outcome measures; learning curves of surgeons were described instead of individual surgeon volumes or summaries were given of previously conducted research on hospital volume and outcomes (no systematic reviews). In total, eight reports were included but seven unique studies were identified, as two different reports described the same study (18,19).
Figure 1

PRISMA flow diagram of the study selection. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analysis.

PRISMA flow diagram of the study selection. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analysis.

Study characteristics

The characteristics of the included studies are described in . The included studies had been conducted in the United States and Australia. The procedures in included studies were obtained from cardiac surgery databases except for Chikwe et al. who used a database that collects data on every ambulatory surgery, hospital discharge and emergency department visit in New York State. The patients in the cardiac surgery databases used by the different studies overlap, since the US regions overlap. This probably accounts for a large proportion of the patients. Furthermore, the Society of Thoracic Surgeons Adult Cardiac Surgery Database has been used two times. The number of procedures per study ranged from 1,054 to 55,311. All studies were retrospective cohort studies and were conducted in the period between 2001–2016 (11,18-24). Repair rate was described in six studies (18-21,23,24). Reoperation was only described by two studies (20,21). Mortality was studied by five studies (11,20-23).
Table 1

Characteristics of included studies

AuthorsStudy periodSetting (database)Study designMV repair or replacementProcedures in total (% male/female)Age (years)Outcome measureConclusion
Badhwar et al. [2020] (20)2011–2016United States (Society of Thoracic Surgeons Adult Cardiac Surgery Database)Retrospective cohort studyMV repair and replacement55,311 (57%/43%)64 [56–73]Operative mortality, 30-day mortality, 30-day weighted composite of mortality/morbidity, successful repair rate, 1-year mortality, reoperation, heart failure re-hospitalizationSurgeon volume was associated with repair rates, 30-day operative mortality, 1-year mortality
Bolling et al. [2010/2011] (18,19)2005–2007North America (Society of Thoracic Surgeons Adult Cardiac Surgery Database)Retrospective cohort studyMV repair and replacement28,507 (48.7%/51.3%)62 [52–72]Repair rateLikelihood of repair is heavily influenced by surgeon volume
Chikwe et al. [2017] (21)2002–2013New York State (Statewide Planning and Research Cooperative System)Retrospective cohort studyMV repair (n=3,660) and replacement (n=1,815)5,475 (49%/51%)59.3All-cause mortality, repair rates, survival, post-repair reoperationsTotal annual surgeon volume of <25 operations was associated with lower repair rates, increased 1-year mortality and less freedom from reoperation
Ch’ng et al. [2015] (11)2001–2010Australia and New Zealand (Australian and New Zealand Society of Cardiac and Thoracic Surgeons)Retrospective cohort studyAll valve surgery11,536 (62.7%/37.3%)67.530-day perioperative mortality, perioperative complicationsProcedure-specific volume and mortality are significantly associated
Hannan et al. [2019] (22)2008–2014New York State (New York’s Cardiac Surgery Reporting System)Retrospective cohort studyMV repair and replacement2,259 (53.4%/46.6%)60.9Mortality, postoperative stroke, congestive heart failure, reoperation, repair rateNo significant difference in mortality among the surgeon volume quartiles
Kilic et al. [2013] (23)2003–200844 states in the US (NIS database)Retrospective cohort studyMV repair and replacement50,152 (52.7%/47.3%)61.9Operative mortality, inpatient hospital costs, repair rateIrrespectively of hospital volume, low surgeon volume significantly increased operative mortality. MV repair rates differ significantly across surgeon volume strata
LaPar et al. [2014] (24)2001–2011Virginia (Virginia Cardiac Surgery Quality Initiative Data Registry)Retrospective cohort studyMV repair (n=2,516) and MV replacement (n=1,662)4,194 (54.1%/45.9%)62.96Repair rateSurgeon volume was more significantly associated than hospital volume with an increased likelihood for repair

MV, mitral valve.

MV, mitral valve.

Methodological study quality

All studies scored the same on the ‘selection’ and ‘comparability’ category (). Only Ch’ng et al. did not score on comparability because they did not retrospectively compare two groups, comparing high- and low-volume surgeons such as in the other studies. Furthermore, six articles scored lower on the ‘outcome’ category due to lack of reported follow-up time (11,19,20,22-24). Moreover, it was unclear if all follow-up data was complete (19) or a description of lost follow-up data was lacking (23). Chikwe et al. scored highest on the NOS scale mainly because the authors applied a long follow-up time and thoroughly reported on missing data (21).
Table 2

Study quality assessment according to the NOS

AuthorsNOS
SelectionComparabilityOutcomeTotal (maximum 8)Quality judgementa
Badhwar et al. [2019] (20)4127High
Bolling et al. [2010] (19)4116Fair
Chikwe et al. [2017] (21)4138High
Ch’ng et al. [2015] (11)426Fair
Hannan et al. [2019] (22)4127High
Kilic et al. [2013] (23)4116Fair
LaPar et al. [2014] (24)4127High

a, ≤5: low methodological quality, 6: fair methodological quality, ≥7: high methodological quality. NOS, Newcastle-Ottawa Scale.

a, ≤5: low methodological quality, 6: fair methodological quality, ≥7: high methodological quality. NOS, Newcastle-Ottawa Scale.

The association between surgeon volume and repair rate

shows reported repair rates for different surgeon volume quartiles per study. Absolute numbers were missing in some studies and are therefore not reported. All ORs were adjusted for confounding variables that may have led to choosing to repair or not, except for Kilic et al. since its ORs were calculated by us (23). Bolling et al. and Kilic et al. both show in their articles that the effect of volume on repair rate was linear in the lower tail and flatter in the upper tail of the volume distribution, suggesting a plateau effect in the association (19,23). Besides the comparison of attempted repair rates (OR =0.34), Badhwar et al. also shows an increased successful repair for higher volume surgeons (OR =0.62) (20).
Table 3

Results of included studies regarding repair rate

AuthorsSurgeon volumesRepair rate (%) per surgeon volumeAOR/OR (95% CI)P value
Badhwar et al. (20)Attempted repair rate:Attempted repair rate:Attempted repair high vs. low volume:
<5.3 MVO77.7%AOR: 0.34 (0.29–0.41)<0.001
>20.9 MVO87.2%
Successful repair rate:Successful repair rate:Successful repair high vs. low:
<5.3 MVO96.7%AOR: 0.62 (0.45–0.85)0.003
>20.9 MVO97.3%
Bolling et al. (18,19)Subgroup analysis:Subgroup analysis:AOR:
5 MVO54.6%5 MVO: reference
10 MVO60.4%10 MVO: 1.5 (1.4–1.6)Unknown
20 MVO69.6%20 MVO: 2.5 (2.0–3.0)
50 MVO80.8%50 MVO: 5.0 (4.0–6.0)
100 MVO82.6%100 MVO: 5.5 (3.5–7.0)
Chikwe et al. (21)AOR:
<10 MVO48.4%<10 MVO: reference
11–24 MVO55.8%11–24 MVO: 1.22 (0.89-1.70)aUnknown
25–50 MVO64.6%25–50 MVO: 1.77 (1.26–2.49)
>51 MVO77.2%>51 MVO: 3.18 (2.02–5.00)
Kilic et al. (23)OR:
10 MVO49%10 MVO: reference
25 MVO53%25 MVO: 1.17 (0.67–2.04)a,b0.572c
100 MVO67%100 MVO: 2.11 (1.19–3.75)b0.01c
LaPar et al. (24)AOR:
<20 MVO39%1.25 (1.04–1.72)<0.0001
>20 MVO67%
Hannan et al. (22)AOR:
<17 MVO69%<17 MVO: reference
18–30 MVO74%18–30 MVO: 1.27 (0.69–2.37)a,b0.434c
31–46 MVO84%31–46 MVO: 2.36 (1.19–4.67)b0.014c
>47 MVO92%>47 MVO: 5.17 (2.24–11.94)b0.0001c

a, not significant; b, OR was not given in the article and was calculated by the authors; c, P value was not given in the article and was calculated by the authors. AOR, adjusted odds ratio; CI, confidence interval; MVO, mitral valve operations; OR, odds ratio.

a, not significant; b, OR was not given in the article and was calculated by the authors; c, P value was not given in the article and was calculated by the authors. AOR, adjusted odds ratio; CI, confidence interval; MVO, mitral valve operations; OR, odds ratio. Three ORs were not statistically significant (ORs =1.17–1.27) (21-23), the remaining ORs were significant (19-21,23,24).

The association between mortality and surgeon volume

Each study reported mortality for different surgeon volume quartiles (). The periods for the mortality rates also differed from operative to 4-year mortality. We studied mortality as perioperative mortality: operative mortality or 30-day mortality (n=3). Besides, we defined a group of 1-year mortality and beyond (n=3) (11,20-23,25). Survival estimates were translated into mortality rates (21).
Table 4

Results of included studies regarding mortality

AuthorsSurgeon volumesMortality (%) per surgeon volumeAOR/HR (95% CI)P value
Badhwar et al. (20)Operative mortality:Operative mortality:High volume as reference:
<5.3 MVO1.42%AOR: 2.27 (1.69–3.04)<0.0001
>20.9 MVO0.70%
30-day mortality:30-day mortality:High volume as reference:
<5.3 MVO1.53%AOR: 2.25 (1.68–3.01)<0.001
>20.9 MVO0.99%
1-year mortality:1-year mortality:High volume as reference:
<5.3 MVO9.37%AHR: 1.60 (1.32–1.93)Unknown
>20.9 MVO6.11%
Chikwe et al. (21)1-year mortality:1-year mortality:AHR:
<10 MVO5.9%<10: reference
11–24 MVO4.2%11–24 MVO: 0.72 (0.42–1.22)a
25–50 MVO3%25–50 MVO: 0.52 (0.31–0.85)Unknown
>51 MVO2.2%>51 MVO: 0.46 (0.28–0.76)
Ch’ng et al. (11)30-day mortality:30-day mortality:OR per 20 extra operations:
3 MVO0%0.84 (0.74–0.95)0.003
10 MVO12%OR per volume group:
20 MVO7%10 MVO: reference
50 MVO4%20 MVO: 0.55 (0.50–0.60)b<0.0001c
110 MVO2%50 MVO: 0.31 (0.27–0.34)b<0.0001c
110 MVO: 0.15 (0.13–0.17)b<0.0001c
Hannan et al. (22)4-year mortality:4-year mortality:>47 MVO vs. other surgeon volume quartiles:
<17 MVO5.5%AHR: 0.63 (0.36–1.09)a0.15
18–30 MVO5.1%AOR: >47 MVO vs. <17 MVO:
31–46 MVO5.9%0.65 (0.18–2.39)a,b0.519c
>47 MVO4.1%
Kilic et al. (23)Operative mortality:Operative mortality:OR (multivariate analysis):
1–6.5 MVO10.1%1–6.5 MVO: 2.22 (1.53–3.23)<0.001
6.6–20.5 MVO6.1%6.6–20.5 MVO: 1.50 (1.07–2.11)0.02
>20.5 MVO4.6%>20.5 MVO: reference

a, not significant; b, OR was not given in the article and was calculated by the authors; c, P value was not given in the article and was calculated by the authors. AOR, adjusted odds ratio; HR, hazard ratio; CI, confidence interval; MVO, mitral valve operations; OR, odds ratio.

a, not significant; b, OR was not given in the article and was calculated by the authors; c, P value was not given in the article and was calculated by the authors. AOR, adjusted odds ratio; HR, hazard ratio; CI, confidence interval; MVO, mitral valve operations; OR, odds ratio. All studies reported AORs, using risk-adjusted mortality and multivariable analyses. The given and calculated ORs, in most cases, were based on mortality rates of low-volume surgeons versus mortality rates of high-volume surgeons, using low-volume as the reference group. Two studies used high-volume as reference group in the calculation of the OR in their studies (20,23). These differences in calculations should not be overlooked in the interpretation of and led to ORs <1, rather than >1. The significant ORs <1 ranged from 0.15-0.84 and the ORs >1 ranged from 1.50–2.27. Chikwe et al. showed that higher annual surgeon volume was significantly associated with lower mortality rates (OR =0.46), P-value was not given (21). Ch’ng et al. reported significantly (OR =0.84, P=0.003) less chance to die per 20 extra MV surgeries per surgeon annually. Decreasing linearity can be seen from 10 MVO in their scatter plot. ORs per surgeon volume from the survival rates in the scatter plot were also significant (ORs =0.15–0.55) (11). Two studies also reported significantly 1.50–2.27 more chance to die perioperatively when operated by an annual low-volume surgeon (20,23). All mortality rates decrease when surgeon volume increases, although one OR was not significant (22).

The association between surgeon volume and reoperations

The reoperation rates that were reported in two studies are shown in . Reoperation is a time dependent variable and was in both studies measured at 1 year. Chikwe et al. used an adjusted HR (AHR), Badhwar et al. did use HR. The difference in reoperation was not significant according to Badhwar et al., considering the CI (HR =1.14, CI: 0.60–2.18). The difference was small and therefore clinically not relevant (20). Chikwe et al. reported a significant AHR of 0.45 comparing a surgeon volume of >25 with <25, meaning a strong decrease in risk of reoperation for patients that are operated by an annual high-volume surgeon (21). One report studied reoperation in MV repair and MV replacement but did not report these per surgeon volume. Therefore, this study was not included in (22).
Table 5

Results of included studies regarding reoperations

AuthorsSurgeon volumesFreedom from reoperation (%) at 1 yearAHR/HR (95% CI)P value
Badhwar et al. (20)<5.3 MVO1.07HR: 1.14 (0.60–2.18)aUnknown
>20.9 MVO0.95
Chikwe et al. (21)<25 MVO3.6AHR: 0.45 (0.26–0.76)0.003
>25 MVO1.3

a, not significant. AHR, adjusted hazard ratio; HR, hazard ratio; CI, confidence interval; MVO, mitral valve operations.

a, not significant. AHR, adjusted hazard ratio; HR, hazard ratio; CI, confidence interval; MVO, mitral valve operations.

Threshold values that might lead to better outcomes

Four studies have proposed threshold values for minimum annual surgeon volumes that might lead to better MV outcomes, see . Bolling et al. only measured repair rate and proposed a minimal annual MV surgeon volume of 40 per year based on literature (19). Another study also defined an inflection point at 20 surgeries per year because surgeons performing >20 mitral operations per year were found to perform MV repair three to four times more likely than surgeons performing <20 mitral operations per year (24). Another study which focused on all three outcomes, set a threshold at 25 MV operations (MVO) per surgeon per year. Surgeons performing <25 MVO per year had significantly higher mortality rates, were significantly more likely to do MV replacements than MV repairs and their patients were significantly more likely to undergo reoperation in long-term follow-up (21). Badhwar et al. defined an inflection point of 35 cases per year for an increase in attempted MV repair, successful MV repair and a decrease in 30-day mortality (20). All studies did find inflection points rather than linear relationships. The mean threshold of the four studies is 30 MV surgeries per year.
Table 6

Proposed threshold values that led to better outcomes

StudyOutcome measuresThreshold value
Bolling et al.Repair rate40
LaPar et al.Repair rate20
Chikwe et al.Repair rate, mortality, reoperation25
Badhwar et al.Repair rate, mortality35

Discussion

This is the first systematic literature review of the association between surgeon volume and outcomes such as repair rate, mortality and reoperation for MV surgery. A total of 7 studies were included representing 158,488 patients in total. Principal findings were that surgeon volume is significantly associated with repair rate and mortality, but evidence regarding the outcome of reoperation is not sufficient since only two studies reported on this yet.

Summary of evidence

The ORs for the association between surgeon volume and repair rate ranged significantly from 1.25–5.5, meaning that patients operated by a surgeon with a high surgeon volume, are 1.25–5.5 times as likely to undergo repair (19-21,23,24). The plateau phase between increased surgeon volume and repair rate that was found in two studies, is also described in terms of a learning curve in the literature. For example, increasing total case volume for a surgeon in pancreaticoduodenectomies or radical prostatectomies does not lead to improvements in outcomes when a plateau in performance is reached. Reaching this plateau takes a certain amount of cases to successfully learn the procedure (13,19,23). ORs also showed that increased mitral surgeon volume was significantly associated with lower mortality rates, for instance meaning 54% less chance to die for patients that are operated by a high-volume surgeon (11,20,21,23). In one study the decrease in mortality for increasing surgeon volume was small and led to an OR that was not significant according to its CI and P value (22). The significant association between surgeon volume and mortality accounts for other procedures in the literature as well. For example, the significant ORs for cardiovascular procedures such as aortic valve replacement and coronary-artery bypass grafting (CABG) ranged from 1.36–1.65 (10). Research regarding ruptured aortoiliac aneurysms for instance, abdominal aortic aneurysm repair and carotid endarterectomies also showed significantly lower mortality rates for high-volume surgeons (26-28). Regarding reoperation, one HR was not significant, and another study reported a strong decrease in risk for reoperation for patients that are operated by an annual high-volume surgeon. No conclusions can be drawn regarding reoperation based on these studies (20,21). Another study showed that low surgeon volume was significantly associated with a higher reoperation rate for lumbar spine surgeries (29). The same result was found for inflatable penile prosthesis surgeries and open incisional hernia repairs (30,31). Whether outcomes are influenced by surgeon volume or hospital volume, depends largely on the sort of procedure. This is influenced by the degree of technical skill and the use of specific intraoperative processes for a particular surgery (10). Since surgeon volume influences outcomes significantly, it is important to define a threshold annual surgeon volume that might lead to better patient outcomes. The mean threshold that can be derived from the four thresholds in this systematic review is 30 MV surgeries per year. This corresponds to the threshold that was defined by Bridgewater et al., who developed standards for best practice by an analysis of existing literature and discussion with multidisciplinary panel. They concluded that surgeons should do at least 25 MV repairs per year (8). Annual surgeon volumes were also recommended for other surgeries in the literature, such as 13–21 per year for colorectal cancer, 11 for angioplasty and 75 for pediatric cardiac surgery to achieve significantly better outcomes (14). Although this review concludes for a threshold of a MV surgeon volume of 30 per year, it remains problematic to define an arbitrary cut-off. For example, a surgeon with 25 repair per year for the past two years, may be just as qualified as a new graduate with an experience of 100 mitral repairs in the past 2 years (12). It is recommended to investigate the difference between low-volume and high-volume groups using arbitrary cut-offs in future research.

Limitations

This systematic review has several limitations. One limitation is that it is unknown whether follow-up data was complete in all articles which led to an unclear quality assessment. Some articles reported that follow-up data was not complete and this could influence the reliability of the outcome measures. Moreover, different surgeon volume quartiles gave different definitions of high and low volume between studies and therefore a meta-analysis was not possible. Further, the amount of overlap in the US cardiac surgery databases included in this study is unknown but it seems that a proportion of patients are duplicate. This implies that less patients are included than it seems, which makes the data less significant. It is also unknown how many MV surgery patients Ch’ng et al. included and this also influences the reliability of the outcomes (11).

Implications

Several potential implications can be drawn from this review. First, MV surgery should preferentially be performed by surgeons with high annual surgery volumes. Therefore, it might be necessary to centralize MV surgery in high-volume hospitals or reference centers. Since volume seems an important factor for better outcomes, specific training in MV repair for cardiac surgeons is important to develop and maintain their surgical skills. For example, this can be done through simulation-based training for cardiac surgery (32). Training was shown to be an essential prerequisite for high quality mitral repair (8). Furthermore, experience is crucial since surgical qualities such as clinical judgment and technical expertise might account for a large part in these volume-outcome relationships (23).

Conclusions

In conclusion, higher surgeon volume is significantly associated with improved outcomes such as repair rate and mortality. Recommendations for further research would be to systematically review the influence of hospital volume on this association between surgeon volume and improved outcomes. The article’s supplementary files as
  31 in total

Review 1.  A systematic review of the impact of volume of surgery and specialization on patient outcome.

Authors:  M M Chowdhury; H Dagash; A Pierro
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

2.  When is your surgeon good enough? When do you need a "referent surgeon"?

Authors:  Patrick M McCarthy
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

3.  The EACTS simulation-based training course for endoscopic mitral valve repair: an air-pilot training concept in action.

Authors:  Peyman Sardari Nia; Samuel Heuts; Jean H T Daemen; Jules R Olsthoorn; W Randolph Chitwood; Jos G Maessen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2020-05-01

4.  Surgeon volume plays a significant role in outcomes and cost following open incisional hernia repair.

Authors:  Christopher T Aquina; Kristin N Kelly; Christian P Probst; James C Iannuzzi; Katia Noyes; Howard N Langstein; John R T Monson; Fergal J Fleming
Journal:  J Gastrointest Surg       Date:  2014-08-14       Impact factor: 3.452

5.  Mitral valve repair rates correlate with surgeon and institutional experience.

Authors:  Damien J LaPar; Gorav Ailawadi; James M Isbell; Ivan K Crosby; John A Kern; Jeffrey B Rich; Alan M Speir; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-28       Impact factor: 5.209

Review 6.  Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art.

Authors:  Michele De Bonis; Ottavio Alfieri; Malcolm Dalrymple-Hay; Benedetto Del Forno; Filip Dulguerov; Gilles Dreyfus
Journal:  Prog Cardiovasc Dis       Date:  2017-11-05       Impact factor: 8.194

7.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

8.  Operative outcomes in mitral valve surgery: combined effect of surgeon and hospital volume in a population-based analysis.

Authors:  Arman Kilic; Ashish S Shah; John V Conte; William A Baumgartner; David D Yuh
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-20       Impact factor: 5.209

9.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

10.  Volume-Outcome Association of Mitral Valve Surgery in the United States.

Authors:  Vinay Badhwar; Sreekanth Vemulapalli; Michael A Mack; A Marc Gillinov; Joanna Chikwe; Joseph A Dearani; Maria V Grau-Sepulveda; Robert Habib; J Scott Rankin; Jeffrey P Jacobs; Patrick M McCarthy; Jordan P Bloom; Paul A Kurlansky; Moritz C Wyler von Ballmoos; Vinod H Thourani; James R Edgerton; Christina M Vassileva; James S Gammie; David M Shahian
Journal:  JAMA Cardiol       Date:  2020-10-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.